A detailed history of Lazard Asset Management LLC transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 559,001 shares of CDMO stock, worth $6.94 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
559,001
Holding current value
$6.94 Million
% of portfolio
0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.7 - $12.45 $3.75 Million - $6.96 Million
559,001 New
559,001 $6.36 Million
Q4 2023

Feb 14, 2024

BUY
$4.64 - $9.56 $250,559 - $516,240
54,000 New
54,000 $351,000
Q2 2023

Aug 14, 2023

BUY
$12.96 - $20.93 $439,706 - $710,113
33,928 Added 26.71%
160,936 $2.25 Million
Q1 2023

May 15, 2023

SELL
$13.48 - $18.79 $1.05 Million - $1.46 Million
-77,656 Reduced 37.94%
127,008 $2.38 Million
Q4 2022

Feb 14, 2023

BUY
$12.61 - $18.74 $2.16 Million - $3.22 Million
171,593 Added 518.86%
204,664 $2.82 Million
Q3 2022

Nov 14, 2022

BUY
$15.33 - $20.36 $18,963 - $25,185
1,237 Added 3.89%
33,071 $632,000
Q2 2022

Aug 09, 2022

SELL
$11.63 - $21.55 $35,343 - $65,490
-3,039 Reduced 8.71%
31,834 $485,000
Q1 2022

May 13, 2022

SELL
$16.63 - $27.73 $24,013 - $40,042
-1,444 Reduced 3.98%
34,873 $710,000
Q4 2021

Feb 09, 2022

BUY
$20.7 - $34.18 $656,852 - $1.08 Million
31,732 Added 692.08%
36,317 $1.06 Million
Q3 2021

Nov 15, 2021

SELL
$19.05 - $28.32 $304 - $453
-16 Reduced 0.35%
4,585 $98,000
Q2 2021

Aug 12, 2021

BUY
$18.93 - $25.65 $14,140 - $19,160
747 Added 19.38%
4,601 $118,000
Q1 2021

May 14, 2021

BUY
$11.86 - $21.77 $45,708 - $83,901
3,854 New
3,854 $70,000
Q4 2020

Feb 11, 2021

SELL
$7.25 - $11.76 $61,037 - $99,007
-8,419 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$6.53 - $8.6 $54,976 - $72,403
8,419 New
8,419 $64,000
Q1 2020

May 14, 2020

SELL
$3.15 - $7.39 $1,890 - $4,434
-600 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$5.01 - $8.16 $3,006 - $4,896
600 New
600 $4,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $771M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.